CHEMOCENTRYX (CCXI) Covered Calls

CHEMOCENTRYX covered calls Chemocentryx, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.

You can sell covered calls on CHEMOCENTRYX to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CCXI (prices last updated Fri 4:16 PM ET):

CHEMOCENTRYX (CCXI) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
12.32 +0.02 12.32 12.50 157K 41 0.6B
Covered Calls For CHEMOCENTRYX (CCXI)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Aug 17 12 0.60 11.90 0.8% 10.1%
Nov 16 12 1.55 10.95 9.6% 29.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.